S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
Canada
TSX
Novo Resources Corp (NVO)
Novo Resources Corp (NVO) News

NVO

Novo Resources (NVO)

Novo Resources Corp

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:NVO

1 2 3 4 5 6 Next >>

Date	Time	Source	Headline	Symbol	Company
08/28/2023	11:14AM	PR Newswire (Canada)	Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NVO.WT	TSX:NVO	Novo Resources Corp
08/28/2023	11:10AM	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trading Halt - NVO.WT	TSX:NVO	Novo Resources Corp
02/05/2021	8:00AM	PR Newswire (Canada)	TMX Group Equity Financing Statistics - January 2021	TSX:NVO	Novo Resources Corp
02/16/2010	7:00AM	PR Newswire (US)	Novo Nordisk Makes Victoza(R) Commercially Available in the United States	TSX:NVO
01/21/2010	2:49PM	PR Newswire (US)	Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'	TSX:NVO
01/14/2010	2:01AM	PR Newswire (US)	Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates	TSX:NVO
01/13/2010	8:43AM	PR Newswire (US)	/K I L L K I L L K I L L - National Changing Diabetes Program/	TSX:NVO
01/12/2010	11:01PM	PR Newswire (US)	Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates	TSX:NVO
12/02/2009	8:00AM	PR Newswire (US)	FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause	TSX:NVO
11/27/2009	8:30AM	PR Newswire (US)	Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows	TSX:NVO
11/26/2009	11:01PM	PR Newswire (US)	Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows	TSX:NVO
11/19/2009	7:00AM	PR Newswire (US)	Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show	TSX:NVO
10/30/2009	8:00AM	PR Newswire (US)	Novo Nordisk is Changing Possibilities in Hemophilia	TSX:NVO
10/20/2009	7:30AM	PR Newswire (US)	Data Analysis Reinforces the Safety Profile of Levemir(R)	TSX:NVO
09/01/2009	8:58AM	PR Newswire (US)	Research Supports Improving 'Scoring' of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary Decisio	TSX:NVO
09/01/2009	7:00AM	PR Newswire (US)	National Changing Diabetes Program Supports Improvements in Health Cost Estimates	TSX:NVO
08/27/2009	8:03AM	PR Newswire (US)	Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families	TSX:NVO
08/12/2009	9:00AM	PR Newswire (US)	Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and Diabetes	TSX:NVO
08/10/2009	8:00AM	PR Newswire (US)	Photos: Norditropin NordiFlex(R) 30 mg/3 mL Prefilled Pen Offers Children Needing a Larger Dose of Growth Hormone a Convenient O	TSX:NVO
08/05/2009	7:30AM	PR Newswire (US)	Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North America	TSX:NVO
07/23/2009	8:00AM	PR Newswire (US)	NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care	TSX:NVO
07/15/2009	12:43PM	PR Newswire (US)	FDA Approves NovoLog(R) Labeling Update	TSX:NVO
07/13/2009	12:51PM	PR Newswire (US)	Diabetes Advocates Call For National Strategy, Leadership to Reduce Diabetes and Advance Detection and Treatment	TSX:NVO
06/28/2009	2:18PM	PR Newswire (US)	Novo Nordisk Insulin Analogs Have Proven Safety Profiles	TSX:NVO
06/13/2009	12:09PM	PR Newswire (US)	Novo Nordisk Warns Customers About Stolen Insulin	TSX:NVO
06/12/2009	9:25AM	PR Newswire (US)	Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media Summit	TSX:NVO
06/08/2009	4:50PM	PR Newswire (US)	The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide	TSX:NVO
06/08/2009	7:00AM	PR Newswire (US)	Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride	TSX:NVO
06/07/2009	9:00AM	PR Newswire (US)	Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162	TSX:NVO
05/20/2009	12:21PM	PR Newswire (US)	Americans Who Don't Know They Have Diabetes Incur $18 Billion in Health Expenses Each Year	TSX:NVO

Showing the most relevant articles for your search:TSX:NVO

1 2 3 4 5 6 Next >>

Vontobel Financial Produ...

WisdomTree Commodity Sec...

Societe Generale Effekten

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions